Suzanne Schubbert

3.2k total citations · 2 hit papers
22 papers, 2.3k citations indexed

About

Suzanne Schubbert is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Suzanne Schubbert has authored 22 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Immunology and 8 papers in Oncology. Recurrent topics in Suzanne Schubbert's work include Protein Tyrosine Phosphatases (12 papers), Galectins and Cancer Biology (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Suzanne Schubbert is often cited by papers focused on Protein Tyrosine Phosphatases (12 papers), Galectins and Cancer Biology (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Suzanne Schubbert collaborates with scholars based in United States, Germany and Norway. Suzanne Schubbert's co-authors include Kevin Shannon, Gideon Bollag, Martin Zenker, Charlotte M. Niemeyer, Christian P. Kratz, Hoa Nguyen, Ineke van der Burgt, Cornelia Klein, Kam Y. J. Zhang and Anita Rauch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Nature reviews. Cancer.

In The Last Decade

Suzanne Schubbert

21 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperactive Ras in developmental disorders and cancer

2007 1.2k citations Suzanne Schubbert, Kevin Shannon et al. Nature reviews. Cancer profile →
Germline KRAS mutations cause Noonan syndrome

2006 514 citations Suzanne Schubbert, Martin Zenker et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Schubbert United States	12	1.7k	736	540	223	208	22	2.3k
Douglas Armellino United States	15	1.3k 0.8×	738 1.0×	247 0.5×	401 1.8×	224 1.1×	18	2.3k
Cornelia Rudolph Germany	18	1.4k 0.8×	523 0.7×	287 0.5×	227 1.0×	110 0.5×	41	2.1k
Marina Holgado-Madruga United States	24	2.4k 1.4×	1.1k 1.4×	534 1.0×	378 1.7×	187 0.9×	33	3.3k
Michelle Kuhne United States	14	933 0.5×	788 1.1×	1.1k 2.0×	162 0.7×	177 0.9×	35	2.2k
Jiro Kikuchi Japan	27	1.5k 0.9×	594 0.8×	352 0.7×	209 0.9×	161 0.8×	89	2.2k
James L. Clements United States	20	1.0k 0.6×	429 0.6×	1.2k 2.3×	166 0.7×	167 0.8×	41	2.3k
Ruth LaPushin United States	24	1.6k 1.0×	547 0.7×	461 0.9×	262 1.2×	191 0.9×	36	2.3k
Franz Kohlhuber Germany	15	1.1k 0.7×	825 1.1×	357 0.7×	281 1.3×	161 0.8×	17	1.8k
Jingda Xu China	17	771 0.5×	643 0.9×	390 0.7×	242 1.1×	145 0.7×	24	1.4k
Minji Jo United States	23	1.6k 0.9×	796 1.1×	444 0.8×	902 4.0×	105 0.5×	33	2.5k

Countries citing papers authored by Suzanne Schubbert

Since Specialization

Citations

This map shows the geographic impact of Suzanne Schubbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Schubbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Schubbert more than expected).

Fields of papers citing papers by Suzanne Schubbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Schubbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Schubbert. The network helps show where Suzanne Schubbert may publish in the future.

Co-authorship network of co-authors of Suzanne Schubbert

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Schubbert. A scholar is included among the top collaborators of Suzanne Schubbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Schubbert. Suzanne Schubbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joslyn, Louis R., Mohammad Jafarnejad, Rajbharan Yadav, et al.. (2025). A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15. European Journal of Pharmaceutical Sciences. 214. 107303–107303.

Clark, Robyn, Dionysos Slaga, Kendra N. Avery, et al.. (2024). IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion. Molecular Cancer Therapeutics. 23(9). 1305–1316. 5 indexed citations

Bernett, Matthew J., Suzanne Schubbert, Michael Hackett, et al.. (2022). Abstract 2080: LAG3-targeted IL15/IL15Rα-Fc (LAG3 x IL15) fusion proteins for preferential TIL expansion. Cancer Research. 82(12_Supplement). 2080–2080. 4 indexed citations

Varma, Rajat, Ke Liu, Kendra N. Avery, et al.. (2018). Regulatory T Cell Selective IL-2-Fc Fusion Proteins for the Treatment of Autoimmune Diseases. Blood. 132(Supplement 1). 3709–3709. 3 indexed citations

Bernett, Matthew J., Rajat Varma, Christine Bonzon, et al.. (2018). Abstract 5565: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure. Cancer Research. 78(13_Supplement). 5565–5565. 10 indexed citations

Lee, Sung‐Hyung, Seung Y. Chu, Rumana Rashid, et al.. (2017). Abstract 3633: Anti-SSTR2 × anti-CD3 bispecific antibody induces potent killing of human tumor cells in vitro and in mice, and stimulates target-dependent T cell activation in monkeys: A potential immunotherapy for neuroendocrine tumors. Cancer Research. 77(13_Supplement). 3633–3633. 11 indexed citations

Schubbert, Suzanne, Jing Jiao, Marcus Ruscetti, et al.. (2015). Methods for PTEN in Stem Cells and Cancer Stem Cells. Methods in molecular biology. 1388. 233–285. 13 indexed citations

Moore, Gregory L., Sung‐Hyung Lee, Suzanne Schubbert, et al.. (2015). Tuning T Cell Affinity Improves Efficacy and Safety of Anti-CD38 × Anti-CD3 Bispecific Antibodies in Monkeys - a Potential Therapy for Multiple Myeloma. Blood. 126(23). 1798–1798. 23 indexed citations

Schubbert, Suzanne, et al.. (2014). Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia. Cancer Research. 74(23). 7048–7059. 38 indexed citations

10.

Guo, Wei, Suzanne Schubbert, Bahram Valamehr, et al.. (2011). Suppression of leukemia development caused by PTEN loss. Proceedings of the National Academy of Sciences. 108(4). 1409–1414. 61 indexed citations

11.

Schubbert, Suzanne, Gideon Bollag, Natalya Lyubynska, et al.. (2007). Biochemical and Functional Characterization of Germ Line KRAS Mutations. Molecular and Cellular Biology. 27(22). 7765–7770. 70 indexed citations

12.

Denayer, Ellen, Annabel Parret, Magdalena Chmara, et al.. (2007). Mutation analysis in Costello syndrome: functional and structural characterization of theHRASp.Lys117Arg mutation. Human Mutation. 29(2). 232–239. 38 indexed citations

13.

Schubbert, Suzanne, Kevin Shannon, & Gideon Bollag. (2007). Hyperactive Ras in developmental disorders and cancer. Nature reviews. Cancer. 7(4). 295–308. 1192 indexed citations breakdown →

14.

Schubbert, Suzanne, Gideon Bollag, & Kevin Shannon. (2007). Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Current Opinion in Genetics & Development. 17(1). 15–22. 89 indexed citations

15.

Søvik, O, Suzanne Schubbert, Gunnar Houge, et al.. (2007). De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. Journal of Medical Genetics. 44(7). e84–e84. 21 indexed citations

16.

Schubbert, Suzanne, Kevin Shannon, & Gideon Bollag. (2007). Erratum: Hyperactive Ras in developmental disorders and cancer. Nature reviews. Cancer. 7(7). 564–564. 9 indexed citations

17.

Schubbert, Suzanne, Martin Zenker, Silke Böll, et al.. (2006). Germline KRAS mutations cause Noonan syndrome. Nature Genetics. 38(3). 331–336. 514 indexed citations breakdown →

18.

Kratz, Christian P., Suzanne Schubbert, Gideon Bollag, et al.. (2006). Germline Mutations in Components of the Ras Signaling Pathway in Noonan Syndrome and Related Disorders. Cell Cycle. 5(15). 1607–1611. 44 indexed citations

19.

Schubbert, Suzanne, Oddmund Sövik, Gideon Bollag, et al.. (2006). Biochemical and Functional Analysis of Germline KRAS Mutations That Cause Disorders of the Noonan Syndrome Spectrum.. Blood. 108(11). 1431–1431. 2 indexed citations

20.

Schubbert, Suzanne, Kenneth Lieuw, Connie M. Lee, et al.. (2005). Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood. 106(1). 311–317. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact